Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
- PMID: 18353530
- DOI: 10.1016/j.eururo.2008.02.047
Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
Comment on
-
Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).Eur Urol. 2009 Feb;55(2):385-92. doi: 10.1016/j.eururo.2008.02.046. Epub 2008 Mar 11. Eur Urol. 2009. PMID: 18353529 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
